Transplantation for alcoholic liver disease

Slides:



Advertisements
Similar presentations
ELTR 12/2008 The Present Evolution of Liver Transplantation 1. General evolution of LT in Europe 2. Donor data 3. Recipient data 4. Indications and results.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Volume 67, Issue 3, Pages (September 2017)
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Volume 32, Issue 2, Pages (February 2000)
The impact of hepatitis E in the liver transplant setting
Volume 56, Issue 1, Pages (January 2012)
Volume 67, Issue 3, Pages (September 2017)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Volume 50, Issue 4, Pages (April 2009)
MELD: the holy grail of organ allocation?
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
Volume 44, Issue 3, Pages (March 2006)
Volume 42, Issue 6, Pages (June 2005)
Primary prevention of variceal haemorrhage: A pharmacological approach
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Immigration and viral hepatitis
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Natural history of hepatitis B
Volume 69, Issue 1, Pages (July 2018)
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results  Bruno Roche, Didier Samuel  Journal.
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Chronic HCV infection and the clonality of intrahepatic T cells
Volume 69, Issue 4, Pages (October 2018)
European Association for the Study of the Liver  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Yasuhiko Sugawara, Masatoshi Makuuchi 
Hepatitis C Virus Infection in the Older Patient
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Cirrhosis and other liver disease in cystic fibrosis
Volume 58, Issue 3, Pages (March 2013)
Volume 62, Issue 3, Pages (March 2015)
Michael Charlton  Clinical Gastroenterology and Hepatology 
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Volume 117, Issue 5, Pages (November 1999)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg 
Volume 67, Issue 3, Pages (September 2017)
Immigration and viral hepatitis
Volume 57, Issue 3, Pages (September 2012)
Evolution of liver transplantation for hepatocellular carcinoma
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 141, Issue 4, Pages (October 2011)
Volume 63, Issue 1, Pages (July 2015)
Volume 122, Issue 4, Pages (April 2002)
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
MELD: the holy grail of organ allocation?
Volume 39, Issue 3, Pages (September 2003)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Outcomes in liver transplantation: Does sex matter?
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Transplantation for alcoholic liver disease James Neuberger, Karl-Heinz Schulz, Christopher Day, Wolfgang Fleig, Gabriela A Berlakovich, Marina Berenguer, Georges-Phillippe Pageaux, Michael Lucey, Yves Horsmans, Andrew Burroughs, Krister Hockerstedt  Journal of Hepatology  Volume 36, Issue 1, Pages 130-137 (January 2002) DOI: 10.1016/S0168-8278(01)00278-1

Fig. 1 (A) Number of liver transplants done in Europe according to the ELTR [1] and the proportion done for ALD. Total number of transplants: ALD 5723 (17%), others 27057. (B) The evolution of transplantation for patients with ALD. The number of patients transplanted in Europe for cirrhosis by year and the proportion of patients grafted for ALD (lower shaded area); data from ELTR [1]. Journal of Hepatology 2002 36, 130-137DOI: (10.1016/S0168-8278(01)00278-1)

Fig. 2 Prevalence of severe hepatic fibrosis in patients at 1 and 5 years after liver transplantation for HCV infection, ALD or both (data (unpublished) from Hospital La Fe, Valencia, Spain. Journal of Hepatology 2002 36, 130-137DOI: (10.1016/S0168-8278(01)00278-1)